Mar. 21, 2026 A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome ...
Sustainabilitycategory Elliott builds stake in Invisalign maker Align Technology, Bloomberg News reports Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results